Go Pro
OTCMKTS:CNTMF

Cansortium Full Year Earnings Report

Cansortium logo
$0.02 0.00 (0.00%)
As of 07/24/2026 02:49 PM Eastern

Cansortium EPS Results

Actual EPS
-$0.16
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
-$0.14

Cansortium Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cansortium Announcement Details

Quarter
Full Year
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Cansortium Earnings Headlines

ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
FLUENT Provides Management Update
FLUENT Reports First Quarter 2026 Results
See More Cansortium Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cansortium? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cansortium and other key companies, straight to your email.

About Cansortium

Cansortium (OTCMKTS:CNTMF), Inc. (OTCMKTS:CNTMF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing, distribution and retail of medical cannabis products in the United States. The company’s operations span from seed to sale, with dedicated cultivation facilities, extraction labs and a network of dispensaries serving registered patients.

Cansortium holds licenses and operates in multiple jurisdictions, including Florida, Pennsylvania, Louisiana, Texas and Puerto Rico. Its product portfolio encompasses cannabis flower, pre-rolls, concentrates, vape cartridges, oils, edibles and topicals, offered under brands such as The+Source, Chroma and Campfire, alongside its private-label formulations.

Founded in 2017 and headquartered in Miami, Cansortium began dispensary operations in Florida in 2018 and has since expanded its footprint into new markets. The company has invested in high-intensity cultivation infrastructure and advanced manufacturing processes to ensure product consistency and supply reliability. Leadership is headed by CEO Daniel O’Connell, who has overseen the company’s growth strategy and digital retail initiatives.

View Cansortium Profile